These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8382975)

  • 1. A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways.
    Fafeur V; O'Hara B; Böhlen P
    Mol Biol Cell; 1993 Feb; 4(2):135-44. PubMed ID: 8382975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action.
    Delomenie C; Wautier-Pepin MP; Chappey O; Wautier JL
    Exp Cell Res; 1993 Jul; 207(1):122-30. PubMed ID: 7686496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites.
    Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD
    Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGF beta receptor subtype and decreases the growth inhibitory response to TGF-beta 1.
    Fafeur V; Terman BI; Blum J; Böhlen P
    Growth Factors; 1990; 3(3):237-45. PubMed ID: 2173937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
    Franzén P; Ichijo H; Miyazono K
    Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor, interferon gamma and dexamethasone regulate N-glycosylation of alpha 1-protease inhibitor in human hepatoma cells.
    Mackiewicz A; Laciak M; Górny A; Baumann H
    Eur J Cell Biol; 1993 Apr; 60(2):331-6. PubMed ID: 8392465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.
    Lu SL; Kawabata M; Imamura T; Miyazono K; Yuasa Y
    Biochem Biophys Res Commun; 1999 Jun; 259(2):385-90. PubMed ID: 10362519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
    Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
    Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.
    Sankar S; Mahooti-Brooks N; Bensen L; McCarthy TL; Centrella M; Madri JA
    J Clin Invest; 1996 Mar; 97(6):1436-46. PubMed ID: 8617876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors.
    Choi ME; Ballermann BJ
    J Biol Chem; 1995 Sep; 270(36):21144-50. PubMed ID: 7673146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatic role of astrocytes: suppression of vascular endothelial cell growth by TGF-beta and other inhibitory factor(s).
    Behzadian MA; Wang XL; Jiang B; Caldwell RB
    Glia; 1995 Dec; 15(4):480-90. PubMed ID: 8926041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production.
    Brooks B; Chapman K; Lawry J; Meager A; Rees RC
    Clin Exp Immunol; 1990 Dec; 82(3):583-9. PubMed ID: 2124961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta 1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes.
    Chin YH; Cai JP; Xu XM
    J Immunol; 1992 Feb; 148(4):1106-12. PubMed ID: 1737929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of basal and tumor necrosis factor-enhanced binding of murine tumor cells to murine endothelium by transforming growth factor-beta 1.
    Bereta J; Bereta M; Coffman FD; Cohen S; Cohen MC
    J Immunol; 1992 May; 148(9):2932-40. PubMed ID: 1315361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.
    Schultz-Cherry S; Murphy-Ullrich JE
    J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II.
    Laiho M; Weis FM; Boyd FT; Ignotz RA; Massagué J
    J Biol Chem; 1991 May; 266(14):9108-12. PubMed ID: 1851167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-α inhibits transforming growth factor-β-stimulated myofibroblastic differentiation and extracellular matrix production in human gingival fibroblasts.
    Arancibia R; Oyarzún A; Silva D; Tobar N; Martínez J; Smith PC
    J Periodontol; 2013 May; 84(5):683-93. PubMed ID: 22813343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta receptor binding and function are decreased in psoriatic dermal endothelium.
    Cai JP; Falanga V; Taylor JR; Chin YH
    J Invest Dermatol; 1996 Feb; 106(2):225-31. PubMed ID: 8601720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.